Concomitant ICV administration of GLP- 1 and GIP significantly reduced food intake, body weight, and alcohol consumption
The PA form requests: Current BMI and weight history for the past 12 months Documentation of at least one obesity-related comorbidity (hypertension, type 2 diabetes, prediabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, or nonalcoholic fatty liver disease) Proof of a "medically supervised weight loss program" within the past 6 months (defined as at least 3 documented visits with a provider or dietitian) Confirmation that the patient has tried and failed at least one other weight-loss intervention (medication, structured diet program, or behavioral therapy) The form is designed to be failed
Pilla R, Suchodolski JS
Together, they explore why the current medical system is built to manage illness rather than create health, and what it truly means to take a proactive, data-driven approach to longevity
And medications are tools powerful ones but never substitutes for true system repair
Who should be considered for GLP-1/GIP Therapy